H.Res. 1434 · 117th Congress · House

Reaffirming the preemptive authority of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 301 et seq.) and the Public Health Service Act (42 U.S.C. 201 et seq.) (including regulations thereunder) with respect to State laws that inhibit access to or use of any reproductive health product.

In Congress· Pursuant to the provisions of H. Res. 1529, H. Res. 1434 is considered passed House.
Introduced
Oct 14, 22
Passed House
Dec 21, 22
Passed Senate
Pending
Sent to President
Pending
Signed into Law
Pending

Executive Summary

This resolution affirms that there is well-established authority for the Food and Drug Administration to approve, license, and otherwise regulate reproductive health products under the Federal Food, Drug, and Cosmetic Act and the Public Health Service Act.

The resolution also affirms that (1) such federal laws preempt (i.e., supersede conflicting state or local laws) any state or local laws that prohibit or limit access to or use of any reproductive health product, and (2) the Department of Justice has authority to enforce the preemptive effect of such federal laws by suing any state or political subdivision of a state that prohibits or limits access to or use of any reproductive health product.

Previous Versions

00Oct 14, 2022

This resolution affirms that there is well-established authority for the Food and Drug Administration to approve, license, and otherwise regulate reproductive health products under the Federal Food, Drug, and Cosmetic Act and the Public Health Service Act.

The resolution also affirms that (1) such federal laws preempt (i.e., supersede conflicting state or local laws) any state or local laws that prohibit or limit access to or use of any reproductive health product, and (2) the Department of Justice has authority to enforce the preemptive effect of such federal laws by suing any state or political subdivision of a state that prohibits or limits access to or use of any reproductive health product.

Action Timeline

7
  1. DEC 21, 2022Floor

    Passed/agreed to in House

    Pursuant to the provisions of H. Res. 1529, H. Res. 1434 is considered passed House.

  2. DEC 21, 2022Floor

    Pursuant to the provisions of H

    Res. 1529, H. Res. 1434 is considered passed House.

  3. OCT 17, 2022Committee

    Referred to the Subcommittee on Health.

  4. OCT 14, 2022IntroReferral

    Introduced in House

  5. OCT 14, 2022IntroReferral

    Introduced in House

  6. OCT 14, 2022IntroReferral

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

  7. OCT 14, 2022IntroReferral

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Committees

3

Health Subcommittee

hsif14

Referred: Oct 17, 2022

Active

Judiciary Committee

hsju00

Referred: Oct 14, 2022

Active

Energy and Commerce Committee

hsif00

Referred: Oct 14, 2022

Active